Wall St futures steady after extended losses on Nvidia, payrolls caution
JW Partners LP, a ten percent owner of Establishment Labs Holdings Inc (NASDAQ:ESTA), reported selling 7,591 common shares of the company on November 6, 2025. The shares were sold at a price of $65.00, totaling $493,415. The transaction comes as ESTA shares have surged nearly 36% in the past week and 92% over the last six months, now trading near their 52-week high of $65.45.
The transaction was disclosed in a Form 4 filing with the Securities and Exchange Commission. Following the sale, JW Partners LP and related entities, including JW Asset Management, LLC, JW Opportunities Fund, LLC, JW GP, LLC, and Jason G. Wild, collectively hold 3,075,194 shares of Establishment Labs Holdings Inc. InvestingPro analysis indicates the stock may be overvalued, with an RSI suggesting overbought territory. Despite strong liquidity with a current ratio of 3.33, the company is not profitable, with a diluted EPS of -$2.82 over the last twelve months. Investors seeking deeper insights can access the comprehensive Pro Research Report, available for ESTA and 1,400+ other US equities.
The filing was signed by Jason Klarreich, Attorney-In-Fact, on behalf of JW Asset Management, LLC.
In other recent news, Establishment Labs has reported its third-quarter 2025 earnings, showcasing a strong financial performance that exceeded expectations. The company posted revenue of $53.8 million, which surpassed consensus estimates by $1.6 million and marked a 33.8% year-over-year growth. The earnings per share were reported at -$0.38, beating the analyst forecast of -$0.51, resulting in a positive surprise of 25.49%. Following these results, Mizuho raised its price target for Establishment Labs to $85, maintaining an Outperform rating due to the strong outlook. Needham also increased its price target to $70 from $48, citing the company’s revenue and adjusted EBITDA exceeding consensus expectations. BTIG joined in by raising its price target to $70 from $62, highlighting the company’s positive Q3 performance and future prospects. Establishment Labs’ management now anticipates 2025 revenue to exceed the midpoint of its previous guidance range. These recent developments indicate a robust performance and optimistic outlook for the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.